Summary: Losing the senses of smell and taste inflicts an emotional, social, and psychological toll comparable to living with some of the world’s most serious chronic illnesses. The new review analyzed years of clinical evidence measuring quality-of-life metrics across a wide array of long-term conditions.
The findings decisively challenge the pervasive societal misconception that olfactory and gustatory impairments are merely superficial inconveniences. Instead, the research reveals a bleak reality for millions of sufferers, documented by exceptionally high rates of clinical depression, persistent social isolation, nutritional issues, and chronic anxiety linked to an underestimated sensory loss.
Key Facts
- Chronic Illness Equivalence: Standardized quality-of-life scores for individuals suffering from smell and taste disorders (SATDs) directly match and frequently fall below those recorded for patients living with diabetes, stroke, heart failure, and Parkinson’s disease.
- The Psychological Burden: Deprived of chemosensory inputs, patients describe a profound sense of emotional numbness and widespread social withdrawal. The study identifies high, recurring rates of clinical depression linked to the loss of daily life’s sensory milestones.
- Nutritional Dysregulation: When eating shifts from a primary pleasure to a purely functional chore, patients experience dramatic metabolic changes. Sufferers face severe weight loss from a complete lack of appetite or experience weight gain after aggressively chasing overly strong or sweet flavor profiles.
- Environmental Safety Anxiety: Beyond emotional distress, the condition induces chronic survival anxiety. Sufferers report feeling persistently unsafe due to their absolute inability to detect hazardous environmental cues like smoke, gas leaks, or spoiled food.
- Systemic Medical Sidelining: Despite rigorous data showing extensive patient misery, healthcare models historically dismiss chemosensory disorders as temporary or minor, resulting in a critical global shortage of diagnostic infrastructure and specialist treatment clinics.
Source: University of East Anglia
University of East Anglia research reveals that smell loss can affect quality of life as severely as conditions including diabetes, stroke, Parkinson’s, and kidney failure.
For millions of people, the ability to smell a morning coffee or taste a home‑cooked meal is something they barely think about.
But a new study shows that when those senses disappear, life can quickly become bleak – with patients reporting levels of misery comparable to some of the most serious chronic illnesses.
The findings challenge the widespread belief that losing smell or taste is merely an inconvenience – and expose what experts say is a dangerous underestimation of just how debilitating these conditions can be.
How the research happened
Researchers reviewed years of medical evidence across dozens of studies comparing quality‑of‑life scores across a wide range of chronic illnesses – including diabetes, stroke, heart failure, asthma, cardiovascular and respiratory conditions.
Lead researcher Prof Carl Philpott, from UEA’s Norwich Medical School, said: “We found that smell and taste disorders consistently produce significant emotional, social and psychological suffering, often rivaling conditions routinely considered life‑altering.
“Patients described loss of pleasure in food, difficulties socialising, heightened anxiety around personal safety – such as being unable to smell smoke or gas – and a disturbing sense of emotional numbness.
“Perhaps most alarming was the fact that rates of depression and social withdrawal among people with smell and taste loss were repeatedly found to be high.”
Food as fuel
The study found that for many sufferers, eating stops being one of life’s pleasures and becomes a purely functional act.
“Smell accounts for most of what people perceive as taste,” said Prof Philpott. “So when this is lost, meals can feel bland, metallic or even repulsive. Some people lose weight due to lack of appetite, while others gain weight after chasing stronger or sweeter flavours.”
The review highlights how this sensory loss strikes at the heart of daily life, disrupting family meals, celebrations and social rituals that most people take for granted.
Despite these profound effects, smell and taste disorders have historically been sidelined by healthcare systems – a situation the authors describe as deeply concerning.
Prof Philpott said: “The problem is that doctors often reassure patients that the problem is minor or temporary, even when symptoms persist for years. Few specialist services exist, and access to treatment remains limited.
“Yet our research shows that when patients fill in standard quality‑of‑life questionnaires, their scores frequently match – or even fall below – those seen in people with recognised long‑term conditions.
Covid woke the world up – but not enough
“The Covid pandemic brought sudden attention to smell loss, known as anosmia, and loss of taste, known as ageusia, as millions experienced the symptoms during infection.
“While many recovered, others were left with permanent or distorted sensory perception – including parosmia, where every day smells become nauseating.
“But our work suggests Covid merely exposed a problem that had existed for decades – one that medicine has been slow to take seriously.”
“Better recognition, investment in specialist clinics, and greater research into treatments are urgently needed – not as a matter of comfort, but of genuine health and wellbeing,” he added.
‘Comparing quality of life in smell and taste disorders with other chronic conditions – a narrative review’ is published in the journal Clinical Otolaryngology.
Key Questions Answered:
A: The olfactory system possesses a unique, direct neuroanatomical link to the brain’s emotional architecture. Unlike other senses, olfactory signals pass directly into the olfactory bulb, which is wired straight into the amygdala (regulating emotion) and the hippocampus (regulating memory). When this pathway is severed, individuals lose an essential biological anchor for emotional memory, situational context, and basic neurochemical reward loops, resulting in a distinct form of emotional numbness.
A: Because smell accounts for the vast majority of flavor perception, its absence reduces eating to a bland, metallic, or sometimes repulsive task. This triggers two unhealthy behavioral extremes: some patients experience severe food avoidance and dangerous weight loss due to a complete absence of sensory reward, while others suffer rapid weight gain by overcompensating with highly processed, excessively sweet, or oversalted foods to elicit a sensory response.
A: The study highlights a troubling systemic neglect where front-line clinicians routinely downplay persistent sensory loss as temporary or minor. Despite objective data revealing severe patient suffering, healthcare systems offer minimal diagnostic pathways, very few dedicated specialist clinics, and heavily restricted access to validated therapies, leaving millions to manage a chronic, life-altering condition entirely isolated.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this olfaction and depression research news
Author: Lisa Horton
Source: University of East Anglia
Contact: Lisa Horton – University of East Anglia
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Comparing Quality of Life in Smell and Taste Disorders With Other Chronic Conditions—A Narrative Review” by Natalia Glibbery, David Turner, Duncan Boak, Carl Philpott. Clinical Otolaryngology
DOI:10.1111/coa.70119
Abstract
Comparing Quality of Life in Smell and Taste Disorders With Other Chronic Conditions—A Narrative Review
Objectives
Smell and taste disorders (SATDs) are increasingly prevalent but remain underrecognised, significantly affecting patients’ physical, social and psychological well-being. We recently published a large cohort study reporting Olfactory Disorder Questionnaire (ODQ), EQ-5D-5L (EuroQol Five-Dimension Five-Level) and EQ-5D-5L Visual Analogue Scale (VAS) scores for patients with SATDs. These results highlight the considerable impact of SATDs on quality of life and mental health. This review seeks to evaluate the disease burden of SATDs by comparing their impact on quality of life and mental health with other chronic conditions, using established metrics such as EQ-5D-5L and BDI from the existing literature.
Methods
A literature review was conducted from 1 January 2010 to 10 August 2024, to identify systematic reviews reporting EQ-5D-5L or BDI values in chronic conditions.
Results
Our findings show that EQ-5D-5L and BDI scores for patients with SATDs are comparable to those reported for other chronic conditions, including diabetes, stroke, cardiovascular, respiratory and ENT disorders.
Conclusion
These results highlight the significant burden olfactory dysfunction imposes on individuals. However, unlike other chronic conditions with established treatment protocols, effective therapies for SATDs remain limited, emphasising a critical gap in both research and care. Increased awareness and further research are essential to develop effective treatments and improve outcomes for this often-overlooked population.
Key Points
- Smell and taste disorders (SATDs) are increasingly prevalent but remain underrecognised.
- They have a significant impact on patients’ quality of life across physical, social and psychological dimensions.
- Effective therapeutic options for SATDs are limited.
- Our findings show that quality of life/depression scores for patients with SATDs are comparable to those reported for other chronic conditions.
- Further research is essential to develop effective treatments and improve outcomes for patients with SATDs.
Conflicts of Interest
Carl Philpott is Associate Editor of the journal and co-author of this article. The other authors declare no conflicts of interest.
